HIPO exec sells 6,105 shares under 10b5-1
Torben Ostergaard reported a sale of 6,105 shares of common stock under a 10b5-1 plan.
Rhea-AI Filing Summary
Torben Ostergaard reported a sale of 6,105 shares of common stock under a 10b5-1 plan. The transaction date is 02/17/2026 and the proceeds shown are $174,391.16. The filing references Restricted Stock Units dated 05/15/2025.
Positive
- None.
Negative
- None.
Insights
Routine Rule 144/10b5-1 sale by an insider; procedural disclosure only.
The filing records a 10b5-1 plan sale of 6,105 shares on 02/17/2026 resulting in proceeds of $174,391.16. This indicates a pre-arranged sale rather than an ad hoc open-market trade.
Timing and mechanics are governed by the plan language; subsequent filings may show additional sales or withholding actions tied to the 05/15/2025 Restricted Stock Units.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the HIPO Form 144 report for Torben Ostergaard?
Was the sale part of a 10b5-1 plan for HIPO insider activity?
AI-generated analysis. How Rhea-AI works. Not financial advice.